These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23312395)

  • 1. Circulating hematopoietic and endothelial progenitor cells in newborn infants: effects of gestational age, postnatal age and clinical stress in the first 3 weeks of life.
    Bui KC; Weems M; Biniwale M; George AA; Zielinska E; Azen CG; Durand M; Abdel-Azim H
    Early Hum Dev; 2013 Jun; 89(6):411-8. PubMed ID: 23312395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.
    Farace F; Gross-Goupil M; Tournay E; Taylor M; Vimond N; Jacques N; Billiot F; Mauguen A; Hill C; Escudier B
    Br J Cancer; 2011 Mar; 104(7):1144-50. PubMed ID: 21386843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants.
    Borghesi A; Massa M; Campanelli R; Garofoli F; Longo S; Cabano R; Mazzucchelli I; Tzialla C; Gavilanes AW; Gazzolo D; Manzoni P; Bollani L; Spinillo A; Rosti V; Stronati M
    Int J Immunopathol Pharmacol; 2013; 26(3):809-16. PubMed ID: 24067483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.
    Jain S; Ward MM; O'Loughlin J; Boeck M; Wiener N; Chuang E; Cigler T; Moore A; Donovan D; Lam C; Cobham MV; Schneider S; Christos P; Baergen RN; Swistel A; Lane ME; Mittal V; Rafii S; Vahdat LT
    Breast Cancer Res Treat; 2012 Feb; 132(1):235-42. PubMed ID: 22160642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.
    Schmidt-Lucke C; Fichtlscherer S; Aicher A; Tschöpe C; Schultheiss HP; Zeiher AM; Dimmeler S
    PLoS One; 2010 Nov; 5(11):e13790. PubMed ID: 21072182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns.
    Kotowski M; Safranow K; Kawa MP; Lewandowska J; Kłos P; Dziedziejko V; Paczkowska E; Czajka R; Celewicz Z; Rudnicki J; Machaliński B
    BMC Pediatr; 2012 Sep; 12():148. PubMed ID: 22985188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood.
    Shields LE; Andrews RG
    Am J Obstet Gynecol; 1998 May; 178(5):931-7. PubMed ID: 9609562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Circulating Hematopoietic Stem/Progenitor Cells in Preterm Infants with Septicemia.
    Leung KT; Lam HS; Chan KY; Sit T; Wong RP; Yu JW; Li K; Ng PC
    Stem Cells Dev; 2016 Dec; 25(23):1780-1787. PubMed ID: 27596606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.
    Lanuti P; Rotta G; Almici C; Avvisati G; Budillon A; Doretto P; Malara N; Marini M; Neva A; Simeone P; Di Gennaro E; Leone A; Falda A; Tozzoli R; Gregorj C; Di Cerbo M; Trunzo V; Mollace V; Marchisio M; Miscia S
    Cytometry A; 2016 Mar; 89(3):259-70. PubMed ID: 26305912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial progenitor cells in premature infants: is there an association with premature birth complications?
    Safranow K; Kotowski M; Lewandowska J; Machalińska A; Dziedziejko V; Czajka R; Celewicz Z; Rudnicki J; Machaliński B
    J Perinat Med; 2012 Mar; 40(4):455-62. PubMed ID: 22752779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia.
    Borghesi A; Massa M; Campanelli R; Bollani L; Tzialla C; Figar TA; Ferrari G; Bonetti E; Chiesa G; de Silvestri A; Spinillo A; Rosti V; Stronati M
    Am J Respir Crit Care Med; 2009 Sep; 180(6):540-6. PubMed ID: 19574444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of circulating hem-endothelial marker RNA levels in preterm infants.
    Strauss T; Metsuyanim S; Pessach I; Shuchan-Eisen I; Kuint J; Dekel B
    BMC Pediatr; 2009 Jun; 9():42. PubMed ID: 19555479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
    Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
    J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preterm Cord Blood Contains a Higher Proportion of Immature Hematopoietic Progenitors Compared to Term Samples.
    Podestà M; Bruschettini M; Cossu C; Sabatini F; Dagnino M; Romantsik O; Spaggiari GM; Ramenghi LA; Frassoni F
    PLoS One; 2015; 10(9):e0138680. PubMed ID: 26417990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematopoietic stem and progenitor cells in human term and preterm neonatal blood.
    Li K; Yau FW; Fok TF; So KW; Li CK; Yuen PM
    Vox Sang; 2001 Apr; 80(3):162-9. PubMed ID: 11449956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of methods for assessment of circulating endothelial progenitor cells.
    George J; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
    Tissue Eng; 2006 Feb; 12(2):331-5. PubMed ID: 16548691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.